NCT07434960|Unknown
Expanded Access for Iberdomide
1 other identifier
IM048-1093
Study Type
expanded_access
Target
N/A
Locations
0 countries
Sites
N/A
Timeline
RegisteredFeb 2026
Brief Summary
This is an expanded access designed to provide access to Iberdomide for eligible participants.
Trial Health
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 20, 2026
Completed7 days until next milestone
First Posted
Study publicly available on registry
February 27, 2026
CompletedLast Updated
February 27, 2026
Status Verified
February 1, 2026
First QC Date
February 20, 2026
Last Update Submit
February 20, 2026
Interventions
IberdomideDRUG
Also known as: BMS-986382
Eligibility Criteria
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Links
MeSH Terms
Interventions
iberdomide
Study Officials
- STUDY DIRECTOR
Bristol-Myers Squibb
Bristol-Myers Squibb
Central Study Contacts
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
CONTACT
First line of the email MUST contain the NCT# and Site #.
CONTACT
Study Design
- Study Type
- expanded access
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 20, 2026
First Posted
February 27, 2026
Last Updated
February 27, 2026
Record last verified: 2026-02